Benefit finding and its influencing factors in patients with thyroid cancer: A retrospective study

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-09-06 DOI:10.1016/j.apjon.2024.100584
Yingjia Qian , Lei Zheng , Jian Li
{"title":"Benefit finding and its influencing factors in patients with thyroid cancer: A retrospective study","authors":"Yingjia Qian ,&nbsp;Lei Zheng ,&nbsp;Jian Li","doi":"10.1016/j.apjon.2024.100584","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To understand the level of benefit finding in patients with thyroid cancer and identify its influencing factors.</div></div><div><h3>Methods</h3><div>This retrospective study included 241 patients with thyroid cancer who underwent surgical treatment at a tertiary hospital in Shanghai from October to December 2022. Data were collected using the General Information Questionnaire, the Chinese Benefit Finding Scale, the Social Support Revalued Scale, and the Medical Coping Modes Questionnaire. Logistic regression analysis was performed to explore factors influencing benefit finding.</div></div><div><h3>Results</h3><div>The total benefit finding score among patients with thyroid cancer was 89.00 (76.00, 101.50). Logistic regression analysis indicated that social support (OR = 1.08, 95% CI: 1.02–1.14) and avoidance coping mode (OR = 1.17, 95% CI: 1.00–1.37) significantly impacted benefit finding (<em>P</em> &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>Patients with thyroid cancer demonstrated a high level of benefit finding. Social support and medical coping modes were identified as key factors influencing benefit finding. Healthcare professionals should focus on enhancing these aspects to improve benefit finding in patients with thyroid cancer.</div></div><div><h3>Trial registration</h3><div>EC REFERENCE No. 2024-133.</div></div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2347562524002063","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To understand the level of benefit finding in patients with thyroid cancer and identify its influencing factors.

Methods

This retrospective study included 241 patients with thyroid cancer who underwent surgical treatment at a tertiary hospital in Shanghai from October to December 2022. Data were collected using the General Information Questionnaire, the Chinese Benefit Finding Scale, the Social Support Revalued Scale, and the Medical Coping Modes Questionnaire. Logistic regression analysis was performed to explore factors influencing benefit finding.

Results

The total benefit finding score among patients with thyroid cancer was 89.00 (76.00, 101.50). Logistic regression analysis indicated that social support (OR = 1.08, 95% CI: 1.02–1.14) and avoidance coping mode (OR = 1.17, 95% CI: 1.00–1.37) significantly impacted benefit finding (P < 0.05).

Conclusions

Patients with thyroid cancer demonstrated a high level of benefit finding. Social support and medical coping modes were identified as key factors influencing benefit finding. Healthcare professionals should focus on enhancing these aspects to improve benefit finding in patients with thyroid cancer.

Trial registration

EC REFERENCE No. 2024-133.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状腺癌患者的获益发现及其影响因素:回顾性研究
方法 本回顾性研究纳入了2022年10月至12月在上海一家三级甲等医院接受手术治疗的241例甲状腺癌患者。研究采用一般信息问卷、中国利益寻找量表、社会支持重估量表和医疗应对模式问卷收集数据。结果甲状腺癌患者的获益总分为 89.00(76.00,101.50)。逻辑回归分析表明,社会支持(OR = 1.08,95% CI:1.02-1.14)和回避应对模式(OR = 1.17,95% CI:1.00-1.37)对受益发现有显著影响(P <0.05)。社会支持和医疗应对模式被认为是影响受益发现的关键因素。医护人员应重点加强这些方面的工作,以提高甲状腺癌患者的获益发现率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1